RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now
The Top Five Long Crowded Stocks in Each U.S. Sector
RxSight Executive Sells Over $328k in Company Stock
BTIG Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $59
BTIG analyst Ryan Zimmerman maintains $RxSight(RXST.US)$ with a buy rating, and maintains the target price at $59.According to TipRanks data, the analyst has a success rate of 45.7% and a total
Here's Why We're Not At All Concerned With RxSight's (NASDAQ:RXST) Cash Burn Situation